Posts Tagged ‘MRAs’

RSS

February 26th, 2013

Mixed Results for Spironolactone in Heart Failure with Preserved Ejection Fraction

Although the mineralocorticoid receptor antagonists spironolactone and eplerenone have been shown to be beneficial in patients with heart failure (HF) with reduced ejection fraction (EF), their role in  HF patients with preserved EF has not been tested until now. Now the results of the Aldo-DHF study (Aldosterone Receptor Blockade in Diastolic Heart Failure), published in […]